Guardant Health
GH
#1043
Rank
S$29.30 B
Marketcap
S$218.35
Share price
-8.83%
Change (1 day)
166.33%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): S-$4.50

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is S-$4.46. In 2025 the company made an earnings per share (EPS) of S-$4.23 an increase over its 2024 EPS that were of S-$4.55.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.506.16%
2025S-$4.23-7.02%
2024S-$4.55-16.82%
2023S-$5.48-33.13%
2022S-$8.1960%
2021S-$5.1255.04%
2020S-$3.30207.14%
2019S-$1.07-19.81%
2018S-$1.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
S-$0.04603-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
S-$3.13-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA